MSB 2.17% $1.13 mesoblast limited

These references have been going on for a number of years now...

  1. 384 Posts.
    lightbulb Created with Sketch. 5
    These references have been going on for a number of years now and to the frustration(understandably) of many holders ...little has transpired. So will it be different this time ?

    Well, a lot has progressed with Japan biotech laws; aGVHD progress  and Disks nicely recruiting (28/26 locations/recruiting). And we now have money in the Bank + CHF Teva progressing rapidly. TEVA's FDA push speak volumes of the platform technology and is a positive for prospective Pharma's.  Yes - I think its different this time round.

    GLTAH.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.